Previously called STS101, the company said Wednesday that the drug’s brand name is Atzumi and is indicated for acute migraine ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...

The FDA just approved a new nasal application for allergy medicine. Pennsylvania law allows for school nurses to train other ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray ... 15 and 30kg. Approved by the US Food and Drug Administration (FDA) in March 2025, the spray is now ...

If you have seasonal allergies, you might be miserable when springtime rolls around. As the temperatures warm and the flowers ...

Please provide your email address to receive an email when new articles are posted on . Atzumi is the first dihydroergotamine-based nasal powder approved for migraine treatment in adults.

Note: After the FDA approves a drug ... for an upper respiratory infection or allergy. Because these are also nasal sprays, it is important to take these medicines at least 1 hour before taking ...

Schroeder, MD, MEng In February, the FDA approved ... your allergies have exploded, let’s bring out the cleanup committee,” which includes antihistamine, nasal sprays and eye drops.